Demonstration of a Longitudinal Concentration Gradient Along Scala Tympani by Sequential Sampling of Perilymph from the Cochlear Apex

ABSTRACTLocal applications of drugs to the inner ear are increasingly being used to treat patients' inner ear disorders. Knowledge of the pharmacokinetics of drugs in the inner ear fluids is essential for a scientific basis for such treatments. When auditory function is of primary interest, the drug's kinetics in scala tympani (ST) must be established. Measurement of drug levels in ST is technically difficult because of the known contamination of perilymph samples taken from the basal cochlear turn with cerebrospinal fluid (CSF). Recently, we reported a technique in which perilymph was sampled from the cochlear apex to minimize the influence of CSF contamination (J. Neurosci. Methods, doi: 10.1016/j.jneumeth.2005.10.008). This technique has now been extended by taking smaller fluid samples sequentially from the cochlear apex, which can be used to quantify drug gradients along ST. The sampling and analysis methods were evaluated using an ionic marker, trimethylphenylammonium (TMPA), that was applied to the round window membrane. After loading perilymph with TMPA, 10 1-μL samples were taken from the cochlear apex. The TMPA content of the samples was consistent with the first sample containing perilymph from apical regions and the fourth or fifth sample containing perilymph from the basal turn. TMPA concentration decreased in subsequent samples, as they increasingly contained CSF that had passed through ST. Sample concentration curves were interpreted quantitatively by simulation of the experiment with a finite element model and by an automated curve-fitting method by which the apical–basal gradient was estimated. The study demonstrates that sequential apical sampling provides drug gradient data for ST perilymph while avoiding the major distortions of sample composition associated with basal turn sampling. The method can be used for any substance for which a sensitive assay is available and is therefore of high relevance for the development of preclinical and clinical strategies for local drug delivery to the inner ear.

[1]  P. E. Stopp,et al.  The effect of cerebrospinal fluid pressure on perilymphatic flow in the opened cochlea. , 1979, Acta oto-laryngologica.

[2]  Joe C. Adams,et al.  Distribution of Gentamicin in the Guinea Pig Inner Ear after Local or Systemic Application , 2003, Journal of the Association for Research in Otolaryngology.

[3]  A. Salt,et al.  Quantitative interpretation of corticosteroid pharmacokinetics in inner fluids using computer simulations , 2003, Hearing Research.

[4]  A. Salt,et al.  Quantification of solute entry into cochlear perilymph through the round window membrane , 2001, Hearing Research.

[5]  F. Scheibe,et al.  On sources of error in the biochemical study of perilymph (guinea-pig) , 2004, Archives of oto-rhino-laryngology.

[6]  Alec N. Salt,et al.  Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid , 2003, Hearing Research.

[7]  Sally L. Gewalt,et al.  Quantitative anatomy of the round window and cochlear aqueduct in guinea pigs , 2001, Hearing Research.

[8]  A. Salt,et al.  Local inner-ear drug delivery and pharmacokinetics. , 2005, Drug discovery today.

[9]  R. Kimura,et al.  Distribution of HRP in the inner ear after injection into the middle ear cavity. , 1984, Acta oto-laryngologica.

[10]  A. Salt,et al.  Perilymph sampling from the cochlear apex: A reliable method to obtain higher purity perilymph samples from scala tympani , 2006, Journal of Neuroscience Methods.

[11]  A. Salt,et al.  Analysis of Gentamicin Kinetics in Fluids of the Inner Ear with Round Window Administration , 2002, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[12]  Jeffrey T Borenstein,et al.  Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[13]  P. Cayé-Thomasen,et al.  Cochlear hair cell loss in single-dose versus continuous round window administration of gentamicin , 2005, Acta oto-laryngologica.

[14]  M. Hoffer,et al.  Use of sustained release vehicles in the treatment of Meniere's disease. , 1997, Otolaryngologic clinics of North America.

[15]  M. Holley,et al.  Keynote review: The auditory system, hearing loss and potential targets for drug development. , 2005, Drug discovery today.

[16]  A. Salt,et al.  Calibration of ion-selective microelectrodes for use with high levels of interfering ions , 1991, Journal of Neuroscience Methods.

[17]  Y. Raphael,et al.  Cochlear gene transfer: round window versus cochleostomy inoculation , 1999, Hearing Research.

[18]  R Thalmann,et al.  Evaluation of procedures to reduce fluid flow in the fistulized guinea-pig cochlea. , 1991, Acta oto-laryngologica.

[19]  Kenji Ohyama,et al.  Volume flow rate of perilymph in the guinea-pig cochlea , 1988, Hearing Research.

[20]  L. Lustig The history of intratympanic drug therapy in otology. , 2004, Otolaryngologic clinics of North America.

[21]  A. Salt,et al.  Perilymph composition in scala tympani of the cochlea: Influence of cerebrospinal fluid , 1989, Hearing Research.

[22]  L. Rybak,et al.  Ototoxicity: therapeutic opportunities. , 2005, Drug discovery today.

[23]  C. Laszlo,et al.  Perilymph Displacement by Cerebrospinal Fluid in the Cochlea , 1973, The Annals of otology, rhinology, and laryngology.